« Back to Record
Citation APA

Campani, C., Galvanin, C., Shim, J. H., Bouattour, M., Touchefeu, Y., Delhoume, V., Rosmorduc, O., Pascale, A., An, J., Lee, H. C., Regnault, H., Thabut, D., Paradis, V., Calderaro, J., Ziol, M., Beaufrère, A., Sayadi, A., Amaddeo, G., Allaire, M., Olivier-Hourmand, I., Metivier, C., Rondini, E., Ronot, M., Ntandja-Wandji, L., Ozenne, V., Sidali, S., Marra, F., Hollande, C., Ganne-Carrié, N., Nahon, P., Lequoy, M., Sharma, R., Paris Liver Cancer Group,, Ningarahi, M., Trepo, E., & Nault, J. C. (2025). The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab. Clinical gastroenterology and hepatology. doi:10.1016/j.cgh.2025.11.018


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/401810

Campani, C., Galvanin, C., Shim, J. H., Bouattour, M., Touchefeu, Y., Delhoume, V., Rosmorduc, O., Pascale, A., An, J., Lee, H. C., Regnault, H., Thabut, D., Paradis, V., Calderaro, J., Ziol, M., Beaufrère, A., Sayadi, A., Amaddeo, G., Allaire, M., Olivier-Hourmand, I., Metivier, C., Rondini, E., Ronot, M., Ntandja-Wandji, L., Ozenne, V., Sidali, S., Marra, F., Hollande, C., Ganne-Carrié, N., Nahon, P., Lequoy, M., Sharma, R., Paris Liver Cancer Group,, Ningarahi, M., Trepo, E., & Nault, J. C. (2025). The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab. Clinical gastroenterology and hepatology. doi:10.1016/j.cgh.2025.11.018